MedCity News has moved forward with its Capsules project. If healthcare is all about the data, then MedCity has to be, too. I know for all of you, there’s a need beyond the great day-to-day insights MedCity delivers on startups, healthcare’s tech-driven innovations and the latest big opportunities in the business of medicine.
Overwhelmingly, you want healthcare business intelligence done right.
Which is why I’m excited about the latest Capsules update. In April, I told you about the project: a partnership with the Spoke Network to provide unique market intelligence on all of healthcare’s industries. We combined MedCity’s journalism with the technology and approach to Spoke. It became Capsules.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Now, though, we’ve gone beyond a Wikipedia meets Dunn & Bradstreet. We’ve created a series of industry lists that focus on everything from wearables to cloud computing in healthcare.
Best of all, all of you can collaborate and add your own insights and lists to the mix (Spoke has ported Rock Health lists, for example, as part of the platform).
Access Capsules directly and search the site for everything from companies to industries to people. But Capsules listings will also increasingly appear at the bottom of MedCity stories, too, and we’ll be building lists and Capsules-driven features to enhance our events.
Our goal is with Capsules that you will be able to find out who funds what, the key people you need to know, as well as major industry news in a matter of minutes. I think many industry professionals will appreciate the transparency, access, and insight Capsules will provide to the growing and changing healthcare space.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
(Disclosure. I’ve been on the Spoke advisory board since 2011).
[Photo from Flickr user Jenna]
